1,3,5-triazaspiro[5.5]undeca-2,4-dienes as selective Mycobacterium tuberculosis dihydrofolate reductase inhibitors with potent whole cell activity
- 1 January 2018
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 144, 262-276
Abstract
No abstract availableKeywords
Funding Information
- National University of Singapore Academic Research Fund (1 R-148-000-205-112)
- Ministry of Health's National Medical Research Council's (NMRC/TCR/011-NUHS/2014)
- National University of Singapore
- National University Health System
- Ministry of Health, National Medical Research Council (NMRC/CG/013/2013)
- Albert Einstein College of Medicine (pMV262)
This publication has 29 references indexed in Scilit:
- para-Aminosalicylic Acid Is a Prodrug Targeting Dihydrofolate Reductase in Mycobacterium tuberculosisJournal of Biological Chemistry, 2013
- Antifolates as effective antimicrobial agents: new generations of trimethoprim analogsMedChemComm, 2013
- Synthesis and antimicrobial activity of N1-benzyl or N1-benzyloxy-1,6-dihydro-1,3,5-triazine-2,4-diaminesBioorganic & Medicinal Chemistry Letters, 2011
- Antifolate agents: a patent review (2006 – 2010)Expert Opinion on Therapeutic Patents, 2011
- Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysisThe Lancet Infectious Diseases, 2009
- Dihydrofolate reductase inhibitors as antibacterial agentsBiochemical Pharmacology, 2006
- DNA and RNA Synthesis: AntifolatesChemical Reviews, 2005
- Interactions of 5-deazapteridine Derivatives withMycobacterium tuberculosisand with Human Dihydrofolate ReductasesJournal of Biomolecular Structure and Dynamics, 2004
- Three-dimensional structure of M. tuberculosis dihydrofolate reductase reveals opportunities for the design of novel tuberculosis drugsJournal of Molecular Biology, 2000
- New use of BCG for recombinant vaccinesNature, 1991